SCHEMBL4630995

SCHEMBL4630995

CC(=O)NN1CCC(c2ccc(-c3cn[nH]c3)cc2)CC1

nearest known ligand 0.46

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
ROCK2 O75116 15/20 0.46
MAP4K1 Q92918 1/20 0.45
HRH3 Q9Y5N1 1/20 0.45
BRD4 O60885 2/20 0.41
CREBBP Q92793 2/20 0.41
GPR119 Q8TDV5 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4661555 0.79 HRH3 (0.50) ROCK2MAP4K1HRH3GPR119
SCHEMBL26130746 0.77 HRH3 (0.54) ROCK2MAP4K1HRH3GPR119
SCHEMBL15492542 0.74 SLC18A3 (0.51) HRH3
SCHEMBL6694502 0.74 NOS1 (0.46)
SCHEMBL4921137 0.74 USP2 (0.48) ROCK2HRH3GPR119
SCHEMBL26127646 0.73 HRH3 (0.47) ROCK2MAP4K1HRH3GPR119
SCHEMBL31402498 0.73 ROCK2 (0.46) ROCK2MAP4K1HRH3GPR119
SCHEMBL4660575 0.71 AKT2 (0.49) ROCK2MAP4K1HRH3
Hydrochloric Acid SCHEMBL26130046 0.70 AKT2 (0.48) ROCK2MAP4K1HRH3
SCHEMBL22324840 0.70 SLC18A3 (0.52) ROCK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1919875-A2 PYRAZOLE DERIVATIVES AND THEIR USE AS PKA AND PKB MODULATORS Astex Therapeutics Limited (GB) 2008-05-14 EP claimed
WO-2006136829-A2 PYRAZOLE DERIVATIVES AND THEIR USE AS PKA AND PKB MODULATORS ASTEX THERAPEUTICS LIMITED (GB) 2006-12-28 WO claimed
EP-1919875-A2 PYRAZOLE DERIVATIVES AND THEIR USE AS PKA AND PKB MODULATORS Astex Therapeutics Limited (GB) 2008-05-14 EP disclosed
WO-2006136829-A2 PYRAZOLE DERIVATIVES AND THEIR USE AS PKA AND PKB MODULATORS ASTEX THERAPEUTICS LIMITED (GB) 2006-12-28 WO disclosed